Epstein File EFTA01951603: Facial and Treat (DS10)

Epstein Index›Documents›EFTA01951603

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA01951603: Facial and Treat (DS10)

CorrespondenceDate unavailableEFTA019516031 keyword hits

1

views

0

shares

0

reactions

0

persons

2

keywords

4

excerpts

Email dated October 9, 2013, from Steven Victor MD containing a press release regarding IntelliCell Biosciences' use of stem cells to treat Bell's palsy, a form of facial paralysis affecting cranial nerve VII. The document discusses complications including chronic taste loss, facial spasms, facial pain, and corneal infections, and references relationships with the FDA for expanding patient treatment.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

facial treat

📋 Key Excerpts4

PersonKeyword

Excerpt 1

Bell's palsy is a form of **facial** paralysis resulting from a dysfunction of the cranial nerve VII (the **facial** nerve) causing an inability to control **facial**

Excerpt 2

Major complications of the condition are chronic loss of taste (ageusia), chronic **facial** spasms, **facial** pain and corneal infections.

Excerpt 3

Steven Victor MD Sent: Wed 10/9/2013 1:32:20 PM Subject: Press Release Diabetes and Bell's Palsy IntelliCell Biosciences Stem Cells Used to Successfully **Treat**